AngioDynamics and C.R. Bard Settle Patent Dispute
Monday, 1 April 2024, 21:30
AngioDynamics Settlement with C.R. Bard
AngioDynamics has recently reached a settlement with C.R. Bard regarding all patent litigation issues.
Key Points:
- Resolution: The agreement brings an end to the legal disputes between the two companies.
- Clarity: Both parties can now move forward with clear intellectual property rights.
- Business Focus: The settlement allows both companies to focus on their core business strategies without legal distractions.
The conclusion of this settlement represents a significant development in the ongoing efforts of AngioDynamics and C.R. Bard to maintain a fair and competitive market.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.